Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized Double-Blind Placebo-Controlled Study of ATI-2042 in Paroxysmal Atrial Fibrillation Patients with Pacemakers
2007-001382-15Phase 2Completed
- Sponsor
- ARYx Therapeutics
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Atrial fibrillation (AFib) comparing ATI-2042 with Placebo (2 arms). Primary endpoint: Reduction in atrial tachyarrhythmia/atrial fibrillation burden. Started Apr 2007; status: completed.
02
Drugs
budiodarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2007-001382-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001382-15.